sar425899 glp-1 glucagon dual agonist sanofi Focus on Glucagon-like Peptide- 1 Target: Drugs Approved or Designed to Treat Obesity-mvanhaasteren.nl Multiagonists Currently in Development. |

GLP Activate Natural Formula, GLP-1 Supplement for Metabolic, Energy, GLP-1 Support, Multiple Probiotics & Vitamins- 90 Capsules Supports Energy & Metabolism - Including GLP-1 support, helps curb cravings and keeps you feeling fuller, longer

Summary GLP-1 RAs offer a multifaceted therapeutic strategy in PD, targeting both central neurodegenerative processes and peripheral metabolic dysfunction

This analysis of survey data finds that over 40% of adults under 65 with private insurance could be indicated for a GLP-1 drug though relatively few have a claim, suggesting that a much smaller share seeks treatment through healthcare providers.

Additionally, several key clinical trial readouts delivered compelling data across multiple indications, for example (see Figure 1): Semaglutide: STEP-HFpEF (functional benefits in HFpEF), STEP-9 (pain reduction in knee osteoarthritis), STEP-10 (reversion to normoglycaemia in pre-diabetic, obese patients), ESSENCE (resolution of MASH, improvement in fibrosis) Tirzepatide: SUMMIT (risk reduction in HFpEF outcomes